Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy

NCT00927186 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00927186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
April 30, 2012
Enrollment
69 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, post-menopausal